Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer

Abroad (travel likely)RecruitingPHASE3

Conditions

Rectal Cancer · pMMR (Microsatellite Stable Rectal Cancer)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Contact: Study coordinator (Kai Han, M.D.) · hankai@sysucc.org.cn · +86-18602042643
Contact: Principal Investigator (Peirong Ding, M.D.)

Study leads

Peirong Ding, M.D.
Principal Investigator
Sun Yat-Sen University Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer

Rectal Cancer

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China

Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer

Rectal Cancer

Abroad (travel likely)RecruitingPHASE2

Richmond, United States · Richmond, United States

Personalized Care Pathways for Bowel Symptoms in Rectal Cancer Patients_contributing Factors (Treatable)

Rectal Cancer · LARS - Low Anterior Resection Syndrome · Active Surveillance

Abroad (travel likely)Recruiting

Leuven, Belgium

Total Neoadjuvant Treatment Combined With Adaptive Radiotherapy for Rectal Cancer

Rectal Cancer

Abroad (travel likely)Recruiting

Bergen, Norway